LABORATORIOS FARMACEUTOCOS ROVI SA EUR0.06 financial statements, including revenue, expenses, profit, and loss
The total revenue of 0ILL for the last quarter is 235.28 M EUR, and it's 0.27% higher compared to the previous quarter. The net income of Q3 24 is 69.15 M EUR.